Reassessment of the indications for ribavirin therapy in respiratory syncytial virus infections

Pediatrics

Volumn 97, Issue 1, 1996, Pages 137-140

  Halsey, N A ^a   Chesney, P J ^a   Gerber, M A ^a   Gromisch, D S ^a   Kohl, S ^a   Marcy, S M ^a   Marks, M I ^a   Murray, D L ^a   Overall Jr , J C ^a   Pickering, L K ^a   Whitley, R J ^a   Yogev, R ^a   Peter, G ^a   Berkelman, R L ^a   Hardgree, M C ^a   Jacobs, R F ^a   MacDonald, N E ^a   Orenstein, W A ^a   Rabinovich, N R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

RIBAVIRIN;

ANTIVIRAL ACTIVITY; DRUG EFFICACY; DRUG INFORMATION; HUMAN; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; REVIEW; VIRUS INFECTION;

ANTIVIRAL AGENTS; BIAS (EPIDEMIOLOGY); CLINICAL TRIALS; HUMANS; RESEARCH DESIGN; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RIBAVIRIN; TREATMENT OUTCOME;

EID: 2442671303     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Hall CB, McBride JT, Walsh EE, et al. Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. N Engl J Med. 1983; 308:1443-1447
2. Taber LH, Knight V, Gilbert BE, et al. Ribavirin aerosol treatment of bronchiolitis associated with respiratory syncytial virus infection in infants Pediatrics 1983;72:613-618
3. Hall CB, McBride JT, Gala CL, Hildreth SW, Schnabel KC. Ribavirin treatment of respiratory syncytial viral infection in infants with underlying cardiopulmonary disease JAMA 1985,254:3047-3051
4. Rodriguez WJ, Kim HW, Brandi CD, et al. Aerosolized ribavirin in the treatment of patients with respiratory syncytial virus disease Pediatr Infect Dis J. 1987,6:159-163
5. Groothuis JR, Woodin KA, Katz R, et al Early ribavirin treatment of respiratory syncytial viral infection in high-risk children. J Pediatr. 1990; 117:792-798
6. Smith DW, Frankel LK, Mathers LH, Tang ATS, Ariagno RL, Prober CG. A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection N Engl J Med. 1991;325:24-29
7. Wheeler JG, Wofford J, Turner RB. Historical cohort evaluation of ribavirin efficacy in respiratory syncytial virus infection. Pediatr Infect Dis J. 1993;12.209-213
8. Meert KL, Sarnaik AP, Gelmini MJ, Lieh-Lai MW. Aerosolized ribavirin in mechanically ventilated children with respiratory syncytial virus lower respiratory tract disease, a prospective, double-blind, randomized trial Crit Care Med 1994,22.566-572
9. Moler FW, Steinhart CM, Ohmit SE, Stidham GL, and The Pediatric Critical Care Study Group. Effectiveness of ribavirin in otherwise well infants with respiratory syncytial virus-associated respiratory failure. J Pediatr In press
10. Law BJ, Wang EE, Stephens D. Ribavirin does not reduce hospital stay (LOS) in patients with respiratory syncytial virus (RSV) lower respiratory tract infection (LRTI). Pediatr Rev 1995;37:110A
11. American Academy of Pediatrics, Committee on Infectious Diseases. Use of ribavirin in the treatment of respiratory syncytial virus infection. Pediatrics 1993,92.501-504
12. Frankel L, Wilson C, Demers R A technique for the administration of ribavirin to mechanically ventilated infants with severe respiratory syncytial virus infection Crit Care Med 1987;15:1051-1054
13. Englund JA, Piedra PA, Jefferson LS, Wilson SZ, Taber LH, Gilbert BE High-dose, short-duration ribavirin aerosol therapy in children with suspected respiratory syncytial virus infection J Pediatr 1990,117: 313-320
14. Englund J, Piedra P, Ahn Y-M High-dose, short-duration ribavirin aerosol therapy compared with standard ribavirin therapy in children with suspected respiratory syncytial virus infection. J Pediatr 1994;125 635-641
15. Conrad DA, Christenson IC, Waner JL, Marks MI Aerosolized ribavirin treatment of respiratory syncytial virus infection in infants hospitalized during an epidemic Pediatr Infect Dis J 1987;6 152-158
16. Krafte-Jacobs B, Holbrook P. Ribavirin in severe respiratory syncytial virus infection. Crit Care Med. 1994;2:541-543
17. Wald E, Dashefsky B. Ribavirin. Red Book Committee recommendations questioned. Pediatrics. 1994;93:672-673
18. MacDonald NE, Hall CB, Suffin SC, Alexson C, Harris PJ, Manning JA. Respiratory syncytial viral infection in infants with congenital heart disease. N Engl J Med. 1982;307:397-400
19. Hall CB, Powell KR, MacDonald NE, et al. Respiratory syncytial viral infection in children with compromised immune function. N Engl J Med. 1986;315:77-81
20. Navas L, Wang E, de Carvalho V, Robinson J, and the Pediatric Investigators Collaborative Network on Infections in Canada. Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian children. J Pediatr. 1992;121:348-354
21. Moler FW, Khan AS, Meliones JN, et al. Respiratory syncytial virus morbidity and mortality estimates in congenital heart disease patients: a recent experience. Crit Care Med. 1992;20:1406-1413
22. Wang EEL, Law BJ, Stephens D, and Other Members of PICNIC. Pediatric/Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. J Pediatr. 1995;126:212-219
23. Hertz N, Englund J, Snover D. Respiratory syncytial virus-induced acute lung injury in adult patients with bone marrow transplants: a clinical approach and review of the literature. Medicine. 1989;68:269-281
24. Harrington R, Hooton T, Hackman R, et al. An outbreak of respiratory syncytial virus in a bone marrow transplant Center. J Infect Dis 1992; 165:987-993
25. Whimbey E, Couch R, Englund J. Respiratory syncytial virus pneumonia in hospitalized adult patients with leukemia. Clin Infect Dis 1995; 21:376-379
26. Feldstein T, Swegarden J, Atwood G. Ribavirin therapy: implementation of hospital guidelines and effect on usage and cost of therapy. Pediatrics. 1995;96:14-17
27. Graham B, Davis T, Tang Y, Gruber W. Immunoprophylaxis and immunotherapy of respiratory syncytial virus-infected mice with respiratory syncytial virus-specific immune serum. Pediatr Res. 1993;34:167-172
28. Gruber W, Wilson S, Throop B, Wyde P. Immunoglobulin administration and ribavirin therapy: efficacy in respiratory syncytial virus infection of the cotton rat. Pediatr Res 1987;21:270-274